Clinitech Laboratory Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	24.59	30.75	7.01	7.84	1.04	3.2
Cash & Short-Term Investments	24.59	30.75	7.01	7.84	1.04	3.2
Cash Growth	-46.54%	338.44%	-10.49%	656.27%	-67.66%	-
Accounts Receivable	19.88	15.41	5.98	4.89	3.64	5.58
Other Receivables	-	0.54	0.38	-	-	-
Receivables	28.71	15.95	6.36	4.89	3.64	5.58
Inventory	6.63	5.29	2.84	1.41	1.56	0.89
Prepaid Expenses	-	0.23	0.29	0.13	0.19	0.12
Other Current Assets	20.02	21.17	10.6	5.38	7.41	6.52
Total Current Assets	79.95	73.39	27.11	19.64	13.84	16.31
Property, Plant & Equipment	19.02	21.19	17.07	18.82	20.53	9.2
Long-Term Investments	0.73	0.73	0.73	1.28	1.4	0.91
Other Intangible Assets	9.95	10.15	9.5	0.08	0.03	0.03
Long-Term Deferred Tax Assets	1.63	1.67	1.67	1.57	1.08	0.89
Other Long-Term Assets	-	-	-	18.94	-	-0
Total Assets	111.27	107.13	56.08	60.33	36.87	27.33
Accounts Payable	6.05	6.28	3.46	4	5.19	4.6
Accrued Expenses	-	5.84	3.55	4.02	1.89	1.39
Short-Term Debt	-	-	5.88	6.71	4.57	0.04
Current Portion of Long-Term Debt	-	-	0.42	0.76	0.72	0.53
Current Income Taxes Payable	-	3.03	1.43	-	-	-
Other Current Liabilities	9.98	1.69	1.59	2.08	1.25	1.11
Total Current Liabilities	16.03	16.83	16.32	17.57	13.62	7.67
Long-Term Debt	1.72	-	2.34	2.82	3.57	4.8
Long-Term Unearned Revenue	-	-	-	14.9	-	-
Pension & Post-Retirement Benefits	2.22	1.99	1.95	1.23	1.21	0.96
Other Long-Term Liabilities	-	-	-	0	-	-0
Total Liabilities	19.97	18.82	20.6	36.53	18.39	13.43
Common Stock	22.82	22.82	16.8	15	15	6.67
Additional Paid-In Capital	-	47.89	5.04	-	-	-
Retained Earnings	-	17.59	13.64	8.81	3.48	7.24
Shareholders' Equity	91.31	88.3	35.48	23.81	18.48	13.9
Total Liabilities & Equity	111.27	107.13	56.08	60.33	36.87	27.33
Total Debt	1.72	-	8.63	10.29	8.86	5.37
Net Cash (Debt)	22.87	30.75	-1.62	-2.46	-7.83	-2.16
Net Cash Per Share	9.51	14.77	-1.03	-1.64	-5.22	-1.44
Filing Date Shares Outstanding	1.58	2.28	2.28	1.5	1.5	1.5
Total Common Shares Outstanding	1.58	2.28	2.28	1.5	1.5	1.5
Working Capital	63.92	56.55	10.8	2.07	0.22	8.64
Book Value Per Share	57.77	38.69	15.55	15.87	12.32	9.27
Tangible Book Value	81.36	78.15	25.98	23.73	18.45	13.88
Tangible Book Value Per Share	51.48	34.24	11.38	15.82	12.30	9.25
Machinery	-	52.68	44.09	35.9	34.74	24.01
Construction In Progress	-	-	-	5.6	4.05	0.83

Source: S&P Global Market Intelligence. Standard template. Financial Sources.